eoadjuvant chemotherapy with gemcitabin plus carboplatin for triple negative breast cancer
Phase 2
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000030215
- Lead Sponsor
- Showa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) severe drug hypersensitivity 2) previous malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method clinical response
- Secondary Outcome Measures
Name Time Method pathological response breast conserving rate adverse effect